Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: A meta-analysis

Table 2 Combination therapy vs banding ligation

Author	Mean age (yr)	Men (%)	Non cirrhotic portal hypertension (%)	Alcoholic liver disease (%)	Child class A-B-C (%)	Size of varices small-medium-large (%)
Combination therapy vs sclerotherapy
Westaby et al[36]	48.6	62	17	43	16-43-41	0-34-66
Jensen et al[37]	46.5	87	0	84	26-45-29	3-32-65
Bertoni et al[38]	59.1	64	0	57	32-32-36	7-46.5-46.5
Gerunda et al[39]	NA	NA	0	50	NA	NA
Lundell et al[40]	56.4	54	0	63	22-27-51	NA
Kanazawa et al[32]	NA	NA	0	NA	NA	NA
Vinel et al[41]	55.7	78	0	89	NA	0-32-68
Acharya et al[42]	34.7	85	11	7	60-40-0	0-0-100
Avgerinos et al[43]	58.2	72	0	26	74-19-7	8-45-47
Villanueva et al[33]	56.8	57.5	0	50	30-70-0	7.5-62.5-30
Vickers et al[44]	55.1	59	15	40	26-51-23	7-26-64
Elsayed et al[34]	43.0	84	0	NA	55-29-16	NA
Benedeto-Stojanov et al[45]	NA	NA	0	NA	NA	NA
Dowidar et al[35]	46.0	90	0	0	45-50-5	20-72.5-7.5
Combination therapy vs banding ligation
Abdel-Rahim et al[46]	NA	NA	NA	NA	NA	NA
Lo et al[12]	52.0	77	0	30	19-47-34	0-42-58
de la Peña et al[13]	60.0	75	0	66	15-56-29	21-54-25

NA: Not available.